ReviewFrontiers in immunology2020

Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.

Joeri Lambrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.